The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Upcoming Events

CDDF Multi-Stakeholder Workshop

Histology independent drug development – is this the future for cancer drugs?

14-15 November 2022, HYBRID WORKSHOP – Amsterdam (NL)

CDDF Webinar

Immunotherapy and Radiotherapy Combinations Part 2: Regulatory Considerations

12 December 2022, online

CDDF Annual Conference

Challenges in clinical trial performance

6 – 8 February 2023, HYBRID CONFERENCE – Noordwijk aan Zee (NL)

CDDF Multi-Stakeholder Workshop

Dose optimization in oncology drug development

3 – 4 April 2023, HYBRID WORKSHOP – Amsterdam (NL)

CDDF Multi-Stakeholder Workshop

Innovative oncology trial designs

18 – 19 September 2023, HYBRID WORKSHOP – Amsterdam (NL)

CDDF Multi-Stakeholder Workshop

Biomarker workshop

13 -14 November 2023, HYBRID WORKSHOP – Amsterdam (NL)

CDDF Joint Meetings

AAADV-ASCO-CDDF JOINT WORKSHOP

The 2022 Global Cancer Drug Development Workshop

14 – 16 September 2022, virtual meeting

 CDDF-AACR-EORTC-EMA-NCI JOINT CONFERENCE

Innovations and Biomarkers in Cancer Drug Development Conference (IBCD2023):

POSTPONED TO SPRING 2023, in-person meeting – Brussels (BE)

 Visit our website to stay informed about CDDF upcoming events!

For information about our data protection policy, please click here.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70